NIRAMAI breast cancer screening test, Thermalytix, is a computer aided diagnostic engine that is powered by Artificial Intelligence. The solution uses a high resolution thermal sensing device and a cloud hosted analytics solution for analyzing the thermal images for reliable, early and accurate breast cancer screening.

Thermalytix cancer screening test has been used by more than 100,000 women in 150+ hospitals/diagnostic center as well as 5000+ screening camps in India. The product is commercially available in India, UAE, Kenya, Philippines, Sweden, Bulgaria and Turkey. Niramai Thermalytix test has obtained a CE Mark for all European countries and regulatory clearance in the above countries.

Niramai Quality Management Processes are certified to be compliant with ISO 13485 and MDSAP. We follow good clinical practices, comply with information security and data privacy policies, as per EU GDPR and US HIPAA requirements.

Results of multiple clinical studies comparing Thermalytix with current standard of care have been published in peer reviewed conference/journals. The results from these clinical trials indicate very high accuracy of Thermalytix that is non-inferior to X-Ray Mammography in general, and 25% better sensitivity than mammography in women with dense breasts.

Things to know about Niramai test:

1. It is painless, radiation-free and safe for women of all ages
2. It is completely privacy-aware i.e. no one touches or sees you while screening
3. There are no side effects of the screening and the screening can be done multiple times
4. The device is a thermal device which captures a heat map of the area and does not capture the actual image
5. Niramai screening and the diagnostic test has regulatory clearance from DCGI (Drug Controller General of India)
6. Our thermal devices are CE certified for safety. FDA has approved Thermography as an adjunct modality for breast cancer screening
7. We have screened over 140,000 women to date. We now have tie-ups with over 200 hospitals and diagnostic centres across India and internationally.